NIH Weekly Funding Opportunities and Policy Notices

Thursday, February 3, 2022 - 12:35am
Notice NOT-CA-22-045 from the NIH Guide for Grants and Contracts
Thursday, February 3, 2022 - 12:28am
Notice NOT-OD-22-065 from the NIH Guide for Grants and Contracts
Thursday, February 3, 2022 - 12:26am
Notice NOT-MH-22-095 from the NIH Guide for Grants and Contracts
Thursday, February 3, 2022 - 12:24am
Notice NOT-MH-22-090 from the NIH Guide for Grants and Contracts
Thursday, February 3, 2022 - 12:22am
Notice NOT-AG-22-009 from the NIH Guide for Grants and Contracts
Thursday, February 3, 2022 - 12:16am
Funding Opportunity PAR-22-110 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) allows for renewal and competitive revision applications, and their resubmissions, for funded U24?Research Resource/Infrastructure?applications?that?support?large-scale, complex research programs focused on?Alzheimers disease (AD) and?Alzheimers disease-related dementias (ADRD).?It is anticipated that such programs will likely involve a team of investigators within a single institution or a consortium of?institutions?and?align with one or more?AD/ADRD implementation research milestones?supporting the?research goals of the??National Plan to Address Alzheimers and Related Dementias.
Thursday, February 3, 2022 - 12:03am
Funding Opportunity PAR-22-101 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.
Thursday, February 3, 2022 - 12:02am
Funding Opportunity PAR-22-100 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.
Wednesday, February 2, 2022 - 11:38pm
Funding Opportunity PAR-22-082 from the NIH Guide for Grants and Contracts. Reissue of PAR-19-189. The purpose of this funding announcement is to encourage pilot research that is not an immediate precursor to testing a service intervention but is consistent with NIMH priorities for services research. While NIMH now requires use of an experimental therapeutics model for all intervention studies, there is recognition that some mission-relevant areas of services research do not involve clinical trials.
Wednesday, February 2, 2022 - 10:39am
Notice NOT-AI-22-026 from the NIH Guide for Grants and Contracts
Wednesday, February 2, 2022 - 10:35am
Notice NOT-CA-22-044 from the NIH Guide for Grants and Contracts
Tuesday, February 1, 2022 - 9:19am
Notice NOT-GM-22-021 from the NIH Guide for Grants and Contracts
Monday, January 31, 2022 - 11:23pm
Notice NOT-EY-22-008 from the NIH Guide for Grants and Contracts
Monday, January 31, 2022 - 9:38am
Funding Opportunity PAR-22-112 from the NIH Guide for Grants and Contracts. NIMH COVID-19 urgent award
Monday, January 31, 2022 - 9:37am
Funding Opportunity PAR-22-113 from the NIH Guide for Grants and Contracts. NIMH COVID-19 urgent award
Monday, January 31, 2022 - 9:14am
Funding Opportunity RFA-HD-23-006 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage integrated and synergistic research in the study of uterine fibroids, endometriosis, adenomyosis, gynecologic pain syndromes, and/or pelvic floor disorders.
Monday, January 31, 2022 - 8:43am
Notice NOT-HL-22-010 from the NIH Guide for Grants and Contracts

Pages